Kranse R - Search Results

1

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

Roobol MJ, Steyerberg EW, Kranse R, Wolters T, van den Bergh RC, Bangma CH, Schröder FH. Roobol MJ, et al. Among authors: kranse r. Eur Urol. 2010 Jan;57(1):79-85. doi: 10.1016/j.eururo.2009.08.025. Epub 2009 Sep 1. Eur Urol. 2010. PMID: 19733959

2

A more advanced clinical stage is positively correlated with an increased prostate cancer detection rate.

Roobol MJ, Kranse R, van der Cruijsen IW, Schröder FH. Roobol MJ, et al. Among authors: kranse r. Urology. 2002 Jan;59(1):91-6. doi: 10.1016/s0090-4295(01)01479-0. Urology. 2002. PMID: 11796288 Clinical Trial.

3

Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy.

de Vries SH, Raaijmakers R, Kranse R, Blijenberg BG, Schröder FH. de Vries SH, et al. Among authors: kranse r. J Urol. 2004 Dec;172(6 Pt 1):2193-6. doi: 10.1097/01.ju.0000140958.31366.9f. J Urol. 2004. PMID: 15538230 Clinical Trial.

4

A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam).

Roobol MJ, Schröder FH, Kranse R; ERSPC, Rotterdam. Roobol MJ, et al. Among authors: kranse r. Prostate. 2006 May 1;66(6):604-12. doi: 10.1002/pros.20352. Prostate. 2006. PMID: 16388508 Clinical Trial.

5

Does PSA velocity predict prostate cancer in pre-screened populations?

Schröder FH, Roobol MJ, van der Kwast TH, Kranse R, Bangma CH. Schröder FH, et al. Among authors: kranse r. Eur Urol. 2006 Mar;49(3):460-5; discussion 465. doi: 10.1016/j.eururo.2005.12.026. Epub 2006 Jan 17. Eur Urol. 2006. PMID: 16442212

6

Should we replace the Gleason score with the amount of high-grade prostate cancer?

Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH. Vis AN, et al. Among authors: kranse r. Eur Urol. 2007 Apr;51(4):931-9. doi: 10.1016/j.eururo.2006.07.051. Epub 2006 Aug 15. Eur Urol. 2007. PMID: 16935413

7

Metastatic disease of screen-detected prostate cancer : characteristics at diagnosis.

Roemeling S, Kranse R, Vis AN, Gosselaar C, van der Kwast TH, Schröder FH. Roemeling S, et al. Among authors: kranse r. Cancer. 2006 Dec 15;107(12):2779-85. doi: 10.1002/cncr.22374. Cancer. 2006. PMID: 17109445 Free article.

8

A graphical device to represent the outcomes of a logistic regression analysis.

Kranse R, Roobol M, Schröder FH. Kranse R, et al. Prostate. 2008 Nov 1;68(15):1674-80. doi: 10.1002/pros.20840. Prostate. 2008. PMID: 18712715

9

Balancing the harms and benefits of early detection of prostate cancer.

van Leeuwen PJ, Connolly D, Tammela TL, Auvinen A, Kranse R, Roobol MJ, Schroder FH, Gavin A. van Leeuwen PJ, et al. Among authors: kranse r. Cancer. 2010 Oct 15;116(20):4857-65. doi: 10.1002/cncr.25474. Cancer. 2010. PMID: 20839233 Free article.

10

Prediction of prostate cancer in unscreened men: external validation of a risk calculator.

van Vugt HA, Roobol MJ, Kranse R, Määttänen L, Finne P, Hugosson J, Bangma CH, Schröder FH, Steyerberg EW. van Vugt HA, et al. Among authors: kranse r. Eur J Cancer. 2011 Apr;47(6):903-9. doi: 10.1016/j.ejca.2010.11.012. Epub 2010 Dec 14. Eur J Cancer. 2011. PMID: 21163642

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters